Gastric Cancer Management and Outcomes
Gastric Cancer Management and Outcomes is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 64k research works in it since 1950. 13.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers represents a comprehensive exploration of gastric cancer, covering topics such as chemotherapy, endoscopic resection, molecular characterization, lymph node dissection, adjuvant and neoadjuvant therapy, clinical practice guidelines, metastatic gastric cancer, and survival analysis.
- Gastric Cancer
- Chemotherapy
- Endoscopic Resection
- Molecular Characterization
- Lymph Node Dissection
- Adjuvant Therapy
- Clinical Practice Guidelines
- Neoadjuvant Chemotherapy
- Metastatic Gastric Cancer
- Survival Analysis
- Research works
- 64k fractional, since 1950
- In the world top 10%
- 8.4k per year above
- Top-10% rate
- 13.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +19% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Gastric Cancer Management and Outcomes research?
By volume, China and the United States publish the most (3.1k and 2k works in 2022–2025).
By volume, 2022–2025
- 1 China 3.1k works
- 2 United States 2k works
- 3 Japan 1.7k works
- 4 South Korea 598 works
- 5 United Kingdom 530 works
- 6 Italy 438 works
- 7 Germany 377 works
- 8 India 362 works
- 9 Spain 274 works
- 10 Russia 250 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Gastric Cancer Management and Outcomes research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Gastric Cancer Management and Outcomes research, followed by Fujian Medical University and Sun Yat-sen University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 82 works
- 2 Fujian Medical UniversityChina 64 works
- 3 Sun Yat-sen UniversityChina 60 works
- 4 The University of Texas MD Anderson Cancer CenterUnited States 59 works
- 5 National Cancer Center Hospital EastJapan 58 works
- 6 Memorial Sloan Kettering Cancer CenterUnited States 51 works
- 7 Cleveland ClinicUnited States 51 works
- 8 Sichuan UniversityChina 49 works
- 9 Nanjing Medical UniversityChina 46 works
- 10 Japanese Foundation For Cancer ResearchJapan 43 works
Who are the leading researchers in Gastric Cancer Management and Outcomes?
The most-cited researchers publishing on Gastric Cancer Management and Outcomes include Patrick M. Bossuyt, Reza Malekzadeh and Gholamreza Roshandel.
- 1 Patrick M. Bossuyt Netherlands 14k citations
- 2 Reza Malekzadeh Iran 6.7k citations
- 3 Gholamreza Roshandel Iran 5.4k citations
- 4 Daniel J. Sargent United States 4.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Gastric Cancer Management and Outcomes research done?
The largest centres of Gastric Cancer Management and Outcomes research in 2022–2025 are Tokyo (Japan), Beijing (China), Seoul (South Korea) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Kashiwa and Plainview.
Largest cities, 2022–2025
Where it is the local speciality
- KashiwaJP · 59.9 works54×
- PlainviewUS · 33.0 works35×
Location quotient: how much more of its research is in Gastric Cancer Management and Outcomes than the world average.
Where is the best place to study Gastric Cancer Management and Outcomes?
Among universities, judged by research, Fujian Medical University, Humanitas University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Fujian Medical UniversityChina | 68.5 | 14.6% | 15.1× | 64 | +126.4% |
| 2 | Humanitas UniversityItaly | 66.8 | 18.2% | 14.7× | 14 | +437.9% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 62.1 | 14.9% | 7.1× | 82 | +97.9% |
| 4 | Wakayama Medical UniversityJapan | 58.0 | 18.8% | 19.0× | 11 | +138.0% |
| 5 | Ulsan CollegeSouth Korea | 57.2 | 18.9% | 14.0× | 16 | +45.6% |
| 6 | Hebei Medical UniversityChina | 56.3 | 18.0% | 9.7× | 24 | +27.5% |
| 7 | Fujita Health UniversityJapan | 55.8 | 18.6% | 12.8× | 10 | +108.5% |
| 8 | Keio UniversityJapan | 55.2 | 19.2% | 7.2× | 31 | +48.7% |
| 9 | Harbin Medical UniversityChina | 54.7 | 16.9% | 9.1× | 22 | +50.9% |
| 10 | Kitasato UniversityJapan | 53.4 | 16.8% | 11.6× | 13 | +67.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Gastric Cancer Management and Outcomes research growing?
Output in 2018–2022 was 19% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Gastric Cancer Management and Outcomes.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.